Fibrinogen fractions in the third trimester of pregnancy and in puerperium

被引:22
作者
Adler, G
Duchinski, T
Jasinska, A
Piotrowska, U
机构
[1] Med Ctr Postgrad Educ, Dept Biochem, PL-01813 Warsaw, Poland
[2] Med Ctr Postgrad Educ, Dept Obstet & Gynaecol, Warsaw, Poland
[3] Med Ctr Postgrad Educ, Diagnost Lab, Warsaw, Poland
关键词
fibrinogen; fibrinogen fractions; C-reactive protein; vaginal delivery; caesarean section;
D O I
10.1016/S0049-3848(99)00190-5
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The concentration of fibrinogen, its fractions, and the concentration of C-reactive protein were determined in 45 healthy pregnant women before and after vaginal (27) or caesarean section (18) delivery. The control group consisted of 33 blood donors. In pregnancy, increased concentration of total fibrinogen and its fractions and a normal concentration of C-reactive protein were noted. Three days after vaginal delivery the concentration of total and high molecular weight fibrinogen fraction decreased slightly and the ratio of high to low molecular weight fibrinogen increased. After caesarean section both total and high molecular weight fibrinogen and the ratio of high to low molecular weight fibrinogen increased. The C-reactive protein concentration increased after either type of delivery. The degree of augmentation, however, was ten times as strong after caesarean section. In all women at the end of puerperium the concentrations of the compounds studied returned to normal values, The results suggest that the mechanisms leading to the increase of fibrinogen during pregnancy and after delivery are different. The increase of all fibrinogen fractions in pregnancy may depend first of all on hormones, whereas the increased proportion of high molecular weight to low molecular weight fibrinogen after delivery depends on the acute phase reaction. The degree of this reaction depends on the type of delivery. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 26 条
[1]
Adler G, 1995, ANN NY ACAD SCI, V762, P388
[2]
Postoperative plasma interleukin-6 in patients with renal cancer correlates with C-reactive protein but not with total fibrinogen or with high molecular weight fibrinogen fraction [J].
Adler, G ;
Eichman, W ;
Szczepanski, M ;
Targonska, I ;
Jasinska, A .
THROMBOSIS RESEARCH, 1998, 89 (05) :243-248
[3]
DEGRADATION OF THE ALPHA-CHAIN OF FIBRIN BY HUMAN NEUTROPHIL ELASTASE REDUCES THE STIMULATING EFFECT OF FIBRIN ON PLASMINOGEN ACTIVATION [J].
BACHGANSMO, ET ;
HALVORSEN, S ;
GODAL, HC ;
SKJONSBERG, OH .
THROMBOSIS RESEARCH, 1994, 75 (03) :307-317
[4]
BILEZIKIAN SB, 1977, BLOOD, V50, P21
[5]
Fibrinogen and plasminogen modifications during oral estradiol replacement therapy [J].
Conard, J ;
Gompel, A ;
Pelissier, C ;
Mirabel, C ;
Basdevant, A .
FERTILITY AND STERILITY, 1997, 68 (03) :449-453
[6]
Eguchi K, 1993, Asia Oceania J Obstet Gynaecol, V19, P109
[7]
ORAL-CONTRACEPTIVES, FIBRINOGEN AND CARDIOVASCULAR RISK [J].
ERNST, E .
ATHEROSCLEROSIS, 1992, 93 (1-2) :1-5
[8]
Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[9]
GAFFNEY PJ, 1992, THROMB HAEMOSTASIS, V68, P428
[10]
Pharmacological approaches and strategies for therapeutic modulation of fibrinogen [J].
Handley, DA ;
Hughes, TE .
THROMBOSIS RESEARCH, 1997, 87 (01) :1-36